Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-12 4:30 pm Sale | 2026-06-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 2,934,015 3.190% | -2,155,000 (-42.35%) | Filing History |
| 2026-07-31 4:01 pm Sale | 2026-06-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Octagon Capital Advisors LP | 3,050,000 3.300% | -2,200,000 (-41.90%) | Filing History |
| 2026-07-27 4:25 pm Purchase | 2026-06-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | BlackRock Inc. BLK | 6,169,250 6.700% | 6,169,250 (New Position) | Filing History |
| 2026-05-15 08:55 am Sale | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 2,238,496 2.440% | -2,445,215 (-52.21%) | Filing History |
| 2026-05-14 4:20 pm Sale | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 5,089,015 5.540% | -1,268,913 (-19.96%) | Filing History |
| 2026-05-14 4:01 pm Purchase | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Octagon Capital Advisors LP | 5,250,000 5.700% | 5,250,000 (New Position) | Filing History |
| 2026-05-12 3:07 pm Sale | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Avidity Partners Management LP | 8,302,808 8.700% | -897,772 (-9.76%) | Filing History |
| 2026-05-08 5:00 pm Purchase | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Soleus Capital Master Fund, L.P. | 6,963,141 7.600% | 2,186,743 (+45.78%) | Filing History |
| 2026-02-17 4:17 pm Unchanged | 2025-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.100% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:09 pm Sale | 2025-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | MPM BioImpact LLC | 10,679,391 11.600% | -4,026,491 (-27.38%) | Filing History |
| 2026-02-03 4:41 pm Purchase | 2026-02-02 | 13G | CONTEXT THERAPEUTICS INC CNTX | Soleus Capital Master Fund, L.P. | 4,776,398 5.200% | 4,776,398 (New Position) | Filing History |
| 2025-11-14 4:27 pm Purchase | 2025-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Avidity Partners Management LP | 9,200,580 9.900% | 74,404 (+0.82%) | Filing History |
| 2025-11-14 1:16 pm Unchanged | 2025-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:11 pm Unchanged | 2025-06-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-08-14 2:28 pm Purchase | 2025-06-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Avidity Partners Management LP | 9,126,176 9.900% | 1,349,880 (+17.36%) | Filing History |
| 2025-05-15 4:44 pm Unchanged | 2025-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-05-15 08:38 am Unchanged | 2025-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Deep Track Capital, LP | 7,419,355 8.270% | 0 (Unchanged) | Filing History |
| 2025-05-09 1:08 pm Unchanged | 2025-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Franklin Resources, Inc. BEN | 4,003,380 4.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 6,357,928 8.480% | 2,266,810 (+55.41%) | Filing History |
| 2025-02-14 4:33 pm Sale | 2024-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Great Point Partners, LLC | 4,683,711 6.250% | -2,251,271 (-32.46%) | Filing History |